Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiwen Du

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|November 19, 2024
A Rare t(X;21)(p11;q22) in Childhood Acute Myeloid Leukemia: Case Report and Literature ReviewYiwen Du, Kun Yang, Yuqian Tang, et al.
Hematology (Amsterdam, Netherlands)|December 10, 2025
Targeted therapy in KMT2Ar AMLYing Zhang, Yankun Yang, Yiwen Du, et al.
Frontiers in Medicine|February 6, 2025
A case report of acute promyelocytic leukemia with myeloid sarcoma of the lumbar spine and literature reviewYiwen Du, Kun Yang, Yantao Ling, et al.
Chemosphere|September 16, 2019
Electrochemical characteristics of the decolorization of three dyes by laccase mediator system (LMS) with synthetic and natural mediatorsYiwen Du, Hua Ma, Liping Huang, et al.
Genes|July 29, 2025
Construction of Gene Regulatory Networks Based on Spatial Multi-Omics Data and Application in Tumor-Boundary AnalysisYiwen Du, Kun Xu, Siwen Zhang, et al.
Journal of Translational Medicine|February 7, 2026
Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systemsYuqian Tang, Jiaxin Li, Wu Ye, et al.
International Journal of Nanomedicine|June 2, 2026
CD71-Targeted and ROS-Responsive Micelles for Homoharringtonine Delivery to Enhance Therapeutic Efficiency Against FLT3-ITD Acute Myeloid LeukemiaYuqian Tang, Jiaxin Li, Wu Ye, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 31, 2026
SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilizationWu Ye, Xia Wu, Yuqian Tang, et al.
Cancer Medicine|April 2, 2025
METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC-1α-MAPK Pathway and PGC-1α-Antioxidant System AxisYuqian Tang, Xiaoyan Liu, Wu Ye, et al.
Frontiers in Immunology|December 5, 2022
Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver diseaseXuanyan Cai, Huiyan Zha, Zhaoxu Yang, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|November 19, 2024
A Rare t(X;21)(p11;q22) in Childhood Acute Myeloid Leukemia: Case Report and Literature ReviewYiwen Du, Kun Yang, Yuqian Tang, et al.
Hematology (Amsterdam, Netherlands)|December 10, 2025
Targeted therapy in KMT2Ar AMLYing Zhang, Yankun Yang, Yiwen Du, et al.
Frontiers in Medicine|February 6, 2025
A case report of acute promyelocytic leukemia with myeloid sarcoma of the lumbar spine and literature reviewYiwen Du, Kun Yang, Yantao Ling, et al.
Chemosphere|September 16, 2019
Electrochemical characteristics of the decolorization of three dyes by laccase mediator system (LMS) with synthetic and natural mediatorsYiwen Du, Hua Ma, Liping Huang, et al.
Genes|July 29, 2025
Construction of Gene Regulatory Networks Based on Spatial Multi-Omics Data and Application in Tumor-Boundary AnalysisYiwen Du, Kun Xu, Siwen Zhang, et al.
Journal of Translational Medicine|February 7, 2026
Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systemsYuqian Tang, Jiaxin Li, Wu Ye, et al.
International Journal of Nanomedicine|June 2, 2026
CD71-Targeted and ROS-Responsive Micelles for Homoharringtonine Delivery to Enhance Therapeutic Efficiency Against FLT3-ITD Acute Myeloid LeukemiaYuqian Tang, Jiaxin Li, Wu Ye, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 31, 2026
SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilizationWu Ye, Xia Wu, Yuqian Tang, et al.
Cancer Medicine|April 2, 2025
METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC-1α-MAPK Pathway and PGC-1α-Antioxidant System AxisYuqian Tang, Xiaoyan Liu, Wu Ye, et al.
Frontiers in Immunology|December 5, 2022
Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver diseaseXuanyan Cai, Huiyan Zha, Zhaoxu Yang, et al.
Pageof 3